244 related articles for article (PubMed ID: 10658902)
21. Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the compare program.
Cleaveland ES; Monks A; Vaigro-Wolff A; Zaharevitz DW; Paull K; Ardalan K; Cooney DA; Ford H
Biochem Pharmacol; 1995 Mar; 49(7):947-54. PubMed ID: 7741767
[TBL] [Abstract][Full Text] [Related]
22. Catalytic enzyme histochemistry and biochemical analysis of dihydroorotate dehydrogenase/oxidase and succinate dehydrogenase in mammalian tissues, cells and mitochondria.
Löffler M; Becker C; Wegerle E; Schuster G
Histochem Cell Biol; 1996 Feb; 105(2):119-28. PubMed ID: 8852433
[TBL] [Abstract][Full Text] [Related]
23. Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase.
Hurt DE; Sutton AE; Clardy J
Bioorg Med Chem Lett; 2006 Mar; 16(6):1610-5. PubMed ID: 16406782
[TBL] [Abstract][Full Text] [Related]
24. Effects of dihydroorotate dehydrogenase (DHODH) inhibitors on the growth of Theileria equi and Babesia caballi in vitro.
Kamyingkird K; Cao S; Tuvshintulga B; Salama A; Mousa AA; Efstratiou A; Nishikawa Y; Yokoyama N; Igarashi I; Xuan X
Exp Parasitol; 2017 May; 176():59-65. PubMed ID: 28286324
[TBL] [Abstract][Full Text] [Related]
25. Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound.
Williamson RA; Yea CM; Robson PA; Curnock AP; Gadher S; Hambleton AB; Woodward K; Bruneau JM; Hambleton P; Moss D; Thomson TA; Spinella-Jaegle S; Morand P; Courtin O; Sautés C; Westwood R; Hercend T; Kuo EA; Ruuth E
J Biol Chem; 1995 Sep; 270(38):22467-72. PubMed ID: 7673235
[TBL] [Abstract][Full Text] [Related]
26. Anti-arthritic effects of KF20444, a new immunosuppressive compound inhibiting dihydroorotate dehydrogenase, on rat collagen-induced arthritis.
Kobayashi K; Nakashima A; Nagata H; Nakajima H; Yamaguchi K; Sato S; Miki I
Inflamm Res; 2001 Jan; 50(1):24-31. PubMed ID: 11235018
[TBL] [Abstract][Full Text] [Related]
27. Purification, characterization and localization of mitochondrial dihydroorotate dehydrogenase in Plasmodium falciparum, human malaria parasite.
Krungkrai J
Biochim Biophys Acta; 1995 Apr; 1243(3):351-60. PubMed ID: 7727509
[TBL] [Abstract][Full Text] [Related]
28. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
Cleaveland ES; Zaharevitz DW; Kelley JA; Paull K; Cooney DA; Ford H
Biochem Biophys Res Commun; 1996 Jun; 223(3):654-9. PubMed ID: 8687451
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum.
Seymour KK; Lyons SD; Phillips L; Rieckmann KH; Christopherson RI
Biochemistry; 1994 May; 33(17):5268-74. PubMed ID: 7909690
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni.
de Mori RM; Aleixo MAA; Zapata LCC; Calil FA; Emery FS; Nonato MC
FEBS J; 2021 Feb; 288(3):930-944. PubMed ID: 32428996
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.
Sainas S; Pippione AC; Giorgis M; Lupino E; Goyal P; Ramondetti C; Buccinnà B; Piccinini M; Braga RC; Andrade CH; Andersson M; Moritzer AC; Friemann R; Mensa S; Al-Kadaraghi S; Boschi D; Lolli ML
Eur J Med Chem; 2017 Mar; 129():287-302. PubMed ID: 28235702
[TBL] [Abstract][Full Text] [Related]
33. Biological effects of the dihydroorotate dehydrogenase inhibitor polyporic acid, a toxic constituent of the mushroom Hapalopilus rutilans, in rats and humans.
Kraft J; Bauer S; Keilhoff G; Miersch J; Wend D; Riemann D; Hirschelmann R; Holzhausen HJ; Langner J
Arch Toxicol; 1998 Nov; 72(11):711-21. PubMed ID: 9879809
[TBL] [Abstract][Full Text] [Related]
34. A preliminary characterization of the Pneumocystis carinii dihydroorotate dehydrogenase.
Ittarat I; Asawamahasakda W; Meshnick SR
J Eukaryot Microbiol; 1994; 41(5):92S. PubMed ID: 7804288
[No Abstract] [Full Text] [Related]
35. The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites.
Walse B; Dufe VT; Svensson B; Fritzson I; Dahlberg L; Khairoullina A; Wellmar U; Al-Karadaghi S
Biochemistry; 2008 Aug; 47(34):8929-36. PubMed ID: 18672895
[TBL] [Abstract][Full Text] [Related]
36. Identification of dihydroorotate dehydrogenase as a relevant drug target for 1-hydroxyquinolones in Toxoplasma gondii.
Hegewald J; Gross U; Bohne W
Mol Biochem Parasitol; 2013 Jul; 190(1):6-15. PubMed ID: 23747278
[TBL] [Abstract][Full Text] [Related]
37. Drosophila melanogaster dihydroorotate dehydrogenase: the N-terminus is important for biological function in vivo but not for catalytic properties in vitro.
Löffler M; Knecht W; Rawls J; Ullrich A; Dietz C
Insect Biochem Mol Biol; 2002 Sep; 32(9):1159-69. PubMed ID: 12213251
[TBL] [Abstract][Full Text] [Related]
38. Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
Calil FA; David JS; Chiappetta ERC; Fumagalli F; Mello RB; Leite FHA; Castilho MS; Emery FS; Nonato MC
Eur J Med Chem; 2019 Apr; 167():357-366. PubMed ID: 30776695
[TBL] [Abstract][Full Text] [Related]
39. Anti-peptide immunoglobulins from rabbit and chicken eggs recognise recombinant human dihydroorotate dehydrogenase and a 44-kDa protein from rat liver mitochondria.
Knecht W; Köhler R; Minét M; Löffler M
Eur J Biochem; 1996 Mar; 236(2):609-13. PubMed ID: 8612635
[TBL] [Abstract][Full Text] [Related]
40. Functional expression of human dihydroorotate dehydrogenase (DHODH) in pyr4 mutants of ustilago maydis allows target validation of DHODH inhibitors in vivo.
Zameitat E; Freymark G; Dietz CD; Löffler M; Bölker M
Appl Environ Microbiol; 2007 May; 73(10):3371-9. PubMed ID: 17369345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
